10x Genomics, Inc. Payments to Acquire Debt Securities, Available-for-sale
10x Genomics, Inc. (TXG) reported Payments to Acquire Debt Securities, Available-for-sale of $49.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-07
- 10x Genomics, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $24.55M, a 50.27% decline year-over-year.
- 10x Genomics, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $24.71M.
- 10x Genomics, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $24.58M, a 49.72% decline year-over-year.
- 10x Genomics, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $49.50M.
- 10x Genomics, Inc. payments to acquire debt securities, available-for-sale for fiscal 2025 was $123.44M, a 152.55% increase from fiscal 2024.
- 10x Genomics, Inc. payments to acquire debt securities, available-for-sale for fiscal 2024 was $48.88M.
- 10x Genomics, Inc. payments to acquire debt securities, available-for-sale for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- 10x Genomics, Inc. payments to acquire debt securities, available-for-sale for fiscal 2022 was $282.87M.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $24.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $49.26M 10-Q · filed 2026-08-07 | $73.84M derived: sum of 3 quarters · filed 2026-08-07 | $123.33M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $24.71M 10-Q · filed 2026-05-08 | $49.29M derived: sum of 2 quarters · filed 2026-05-08 | $98.79M derived: sum of 3 quarters · filed 2026-05-08 | $148.15M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $24.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $74.07M derived: sum of 2 quarters · filed 2026-02-13 | $123.44M derived: sum of 3 quarters · filed 2026-08-07 | $123.44M 10-K · filed 2026-02-13 |
| 2025-09-30 | $49.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $98.86M derived: sum of 2 quarters · filed 2026-08-07 | $98.86M 10-Q · filed 2025-11-07 | $147.74M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $49.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $49.36M 10-Q · filed 2026-08-07 | $98.24M derived: sum of 3 quarters · filed 2026-08-07 | $98.24M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | $48.88M derived: sum of 2 quarters · filed 2026-05-08 | $48.88M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $48.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $48.88M derived: sum of 2 quarters · filed 2026-02-13 | $48.88M 10-K · filed 2026-02-13 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | $0.00 derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | $0.00 derived: sum of 3 quarters · filed 2025-02-13 | $11.32M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $11.32M derived: sum of 3 quarters · filed 2025-02-13 | $40.54M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $11.32M derived: sum of 2 quarters · filed 2025-02-13 | $40.54M derived: sum of 3 quarters · filed 2025-02-13 | $282.87M 10-K · filed 2025-02-13 |
| 2022-09-30 | $11.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $40.54M derived: sum of 2 quarters · filed 2023-11-03 | $282.87M 10-Q · filed 2023-11-03 | $282.87M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $29.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $271.55M 10-Q · filed 2023-08-04 | $271.55M derived: sum of 3 quarters · filed 2024-02-15 | $271.55M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $242.33M 10-Q · filed 2023-05-04 | $242.33M derived: sum of 2 quarters · filed 2024-02-15 | $242.33M derived: sum of 3 quarters · filed 2024-02-15 | $242.33M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $0.00 derived: sum of 2 quarters · filed 2024-02-15 | $0.00 derived: sum of 3 quarters · filed 2024-02-15 | $0.00 10-K · filed 2024-02-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-16 |